Thomas Vrekoussis

Prof. Thomas Vrekoussis

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AMAntonis Makrigiannakis
Antonis Makrigiannakis
TVThomas Vrekoussis
Thomas Vrekoussis
EZEmmanouel Zoumakis
Emmanouel Zoumakis
KSKalantaridou N Sophia
Kalantaridou N Sophia
Udo JeschkeUdo Jeschke
Udo Jeschke
Embryo implantation is a complex process involving continuous molecular cross-talk between the embryo and the decidua. One of the key molecules during this process is human chorionic gonadotropin (HCG). HCG effectively modulates several metabolic pathways within the decidua contributing to endometrial receptivity. Herein, a brief overview of the molecular mechanisms regulated by HCG is presented. Furthermore, we summarize the existing evidence regarding the clinical impact on reproductive outcomes after endometrial priming with HCG prior to embryo transfer. Although promising, further evidence is needed to clarify the protocol that would lead to beneficial outcomes.

9 February 2019 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
AMAntonis Makrigiannakis
Antonis Makrigiannakis
TVThomas Vrekoussis
Thomas Vrekoussis
FMFanourios Makrygiannakis
Fanourios Makrygiannakis
HRHalil Ruso
Halil Ruso
KSKalantaridou N Sophia
Kalantaridou N Sophia
TGTimur Gurgan
Timur Gurgan

3 January 2018 in Current Molecular Pharmacology
Verified
Journal Article
Closed access
AMAntonis Makrigiannakis
Antonis Makrigiannakis
TVThomas Vrekoussis
Thomas Vrekoussis
EZEmmanuel Zoumakis
Emmanuel Zoumakis
INIordanis Navrozoglou
Iordanis Navrozoglou
KSKalantaridou N Sophia
Kalantaridou N Sophia
Corticotropin releasing hormone (CRH), the main peptide-mediator of stress, has been found in the female reproductive system. Herein, the role of CRH receptors in the female reproductive sysem is presented. It is clear that CRH receptors are involved in the regulation of the hypothalamic-pituitary-ovarian axis, while locally are associated with decidualization, embryonic implantation, early fetal development and triggering of parturition. Abnormal CRH signalling may contribute to obstetrical pathophysiology, such as pre-eclampsia, abnormal placenta invasion, endometrial growth retardation and preterm delivery.

12 March 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ECEvangelia Chryssou
Evangelia Chryssou
GMGeorgios Manikis
Georgios Manikis
Georgios S. IoannidisGeorgios S. Ioannidis
Georgios S. Ioannidis
Vrettos (Victor) Theodore Chaniotis (Haniotis)Vrettos (Victor) Theodore Chaniotis (Haniotis)
Vrettos (Victor) Theodore Chaniotis (Haniotis)
TVThomas Vrekoussis
Thomas Vrekoussis
AKApostolos Karantanas
Apostolos Karantanas
The aim of this study is to investigate the possibility of predicting histological grade in patients with endometrial cancer on the basis of intravoxel incoherent motion (IVIM)-related histogram analysis parameters. This prospective study included 52 women with endometrial cancer (EC) who underwent MR imaging as initial staging in our hospital, allocated into low-grade (G1 and G2) and high-grade (G3) tumors according to the pathology reports. Regions of interest (ROIs) were drawn on the diffusion weighted images and apparent diffusion coefficient (ADC), true diffusivity (D), and perfusion fraction (f) using diffusion models were computed. Mean, median, skewness, kurtosis, and interquartile range (IQR) were calculated from the whole-tumor histogram. The IQR of the diffusion coefficient (D) was significantly lower in the low-grade tumors from that of the high-grade group with an adjusted p-value of less than 5% (0.048). The ROC curve analysis results of the statistically significant IQR of the D yielded an accuracy, sensitivity, and specificity of 74.5%, 70.1%, and 76.5% respectively, for discriminating low from high-grade tumors, with an optimal cutoff of 0.206 (×10−3 mm2/s) and an AUC of 75.4% (95% CI: 62.1 to 88.8). The IVIM modeling coupled with histogram analysis techniques is promising for preoperative differentiation between low- and high-grade EC tumors.

29 June 2023 in Clinical and Translational Oncology
Verified
Journal Article
Open access
PDF file
ADAngelos Dimas
Angelos Dimas
AGAnna C. Goussia
Anna C. Goussia
APAlexanndra Papoudou-Bai
Alexanndra Papoudou-Bai
APAnastasia Politi
Anastasia Politi
MPMinas Paschopoulos
Minas Paschopoulos
TVThomas Vrekoussis
Thomas Vrekoussis
Objectives: To examine the relation of corticotropin-releasing hormone (CRH) family peptides with inflammatory processes and oncogenesis, emphasizing in vulvar inflammatory, premalignant and malignant lesions, as well as to investigate the possibility of lesion cells immunoescaping, utilizing FAS/FAS-L complex. Methods: Immunohistochemical expression of CRH, urocortin (UCN), FasL and their receptors CRHR1, CRHR2 and Fas was studied in vulvar tissue sections obtained from patients with histologically confirmed diagnosis of lichen, vulvar intraepithelial neoplasia (VIN) and vulvar squamous cell carcinoma (VSCC). The patient cohort was selected from a tertiary teaching Hospital in Greece, between 2005 and 2015. For each of the disease categories, immunohistochemical staining was evaluated and the results were statistically compared. Results: A progressive increase of the cytoplasmic immunohistochemical expression of CRH and UCN, from precancerous lesions to VSCC was observed. A similar increase was detected for Fas and FasL expression. Nuclear localization of UCN was demonstrated in both premalignant and VSCC lesions, with staining being significantly intensified in carcinomas, particularly in the less differentiated tumor areas or in the areas at invasive tumor front. Conclusions: Stress response system and CRH family peptides seem to have a role in inflammation maintenance and progression of vulvar premalignant lesions to malignancy. It seems that stress peptides may locally modulate the stroma through Fas/FasL upregulation, possibly contributing to vulvar cancer development.

29 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FMFanourios Ioannis Makrygiannakis
Fanourios Ioannis Makrygiannakis
MMMaria Marmara
Maria Marmara
TVThomas Vrekoussis
Thomas Vrekoussis
Dragana NikitovicDragana Nikitovic
Dragana Nikitovic
AMAntonis Makrigiannakis
Antonis Makrigiannakis
Aikaterini BerdiakiAikaterini Berdiaki
Aikaterini Berdiaki
Background/Objectives: Aging is increasingly recognized as a key determinant of changes in human tissue and cellular function. Women’s age, in particular, has been associated with reduced oocyte quality and negatively correlated with the expression of genes involved in endometrial decidualization and cellular function. The ability of endometrial cells to interact and allow the invasion of the growing embryo is defined as endometrial receptivity. Investigating age-related differences in human endometrial receptivity may expand our understanding of factors contributing to infertility. Methods: Stromal cells were isolated and cultured from endometrial pipelle biopsies (n = 28) obtained from female donors at the proliferative phase of the menstrual cycle. Protein and mRNA expression of the receptivity modulators OPN, CD44, and HOXA10 were analyzed by Western blot and real-time PCR, respectively. Results: Data presented a linear decrease in mRNA expression of OPN and HOXA10 (p = 0.0066, R2 = 0.3018 and p = 0.0036, R2 = 0.529, respectively) with women’s increasing age, and a similar trend was evident at the protein level (OPN, p < 0.05; HOXA10, p < 0.01). Further analysis of the data included separating the samples into three age groups: 25–35 years, 36–40 years, and 41–46 years. ANOVA revealed a significant decrease in OPN and HOXA10 mRNA expression (p = 0.03158 and p = 0.02578, respectively). CD44 expression did not differ with age. Conclusions: OPN and HOXA10 are negatively correlated with increasing maternal age. These findings suggest that age-related alterations in key endometrial receptivity modulators may contribute to impaired implantation and could represent potential targets for diagnostic or therapeutic strategies in human implantation failure.